Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
Issue #146, January 2020
A Texas federal judge has denied Ethicon Inc. and Johnson & Johnson summary judgment on breach of warranty, constructive fraud, and unjust enrichment claims in a pelvic mesh case, ruling that questions of fact exist as to the viability of each claim.
A Nevada federal judge has dismissed as preempted a failure-to-warn claim asserted against the maker of a generic epilepsy drug, noting that the defendant is barred by federal law from changing the drug’s label to add additional warnings.
Plaintiffs cannot sue a defendant that had been previously dismissed from the case with prejudice unless the order is changed by the judge or vacated by an appellate court, a Pennsylvania federal judge has ruled in two Ethicon pelvic mesh cases.
Strict liability and negligence claims in a lawsuit targeting Medtronic’s deep brain stimulator devices are expressly preempted because they seek to impose state law claims that are “different from, or in addition to” federal regulations, a Pennsylvania federal judge has ruled.
The Food and Drug Administration is warning that certain seizure and nerve pain drugs can cause serious breathing difficulties in patients who have lung problems or when used in conjunction with drugs that depress the central nervous system (CNS), such as opioid painkillers.
An Idaho federal judge has awarded Ethicon and Johnson & Johnson summary judgment in a case targeting their hernia repair mesh, finding the plaintiffs failed to prove that the product caused the plaintiff to suffer a bowel obstruction.
A federal appeals panel has reinstated a lawsuit in which two health benefit plans accuse GlaxoSmithKline of concealing the risks posed by its type-2 diabetes drug Avandia, ruling that the state law consumer protection claims are not preempted by federal law.
Issue #145, December 2019
The U.S. Judicial Panel on Multidistrict Litigation has created a multidistrict litigation docket for claims asserted against Allergan for its Biocell textured breast implants, sending the lawsuits to the District of New Jersey.
A Washington federal judge has allowed the plaintiff in a spinal fusion device case to add three healthcare providers as defendants, ruling that failure to join them might result in separate and redundant actions.
A Louisiana federal judge has allowed an inadequate warning claim to proceed against the makers of blood coagulation test strips, ruling that the plaintiffs adequately alleged that their physician was not warned of the product’s possible malfunction.